Human Motion Insitute

Human Motion Institute

back to publications

Survival, and time to an advanced disease state or progression, of untreated patients with moderately severe MS in a multicenter observational database - Relevance for design of a clinical trial for high dose immunosuppressive therapy with...

Daumer M., Griffith L., Meister W., Nash R., Wolinsky J.: Multiple Sclerosis 12, p. 174-179

full title:
Survival, and time to an advanced disease state or progression, of untreated patients with moderately
severe MS in a multicenter observational database - Relevance for design of a clinical trial for high dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation.

European Union Framework 7 BMBF - Federal Ministry of Education and Research BMWI - Federal Ministry of Business and Technology Deutsches Kompetenznetzwerk Multiple Sklerose Hertie Foundation University of Oxford, UK Imperial College, London, UK Bavarian Research Foundation University of Cambridge Mayo Clinic, US University of Rochester, US US National MS Society UK Multiple Sclerosis Society Hilton Foundation, US GE Healthcare European Medicines Agency
This site uses 2 temporary cookies. A session cookie to navigate the platform and a cookie protecting your form input from Cross Site Request Forgery.